<p>野村資產管理有限公司在第二季度增持了 Astera Labs, Inc.（NASDAQ:ALAB - 免費報告）50.2% 的股份，根據其最近向證券交易委員會提交的文件顯示。這家機構投資者在此期間購買了額外的 199,330 股後，持有該公司 596,130 股股票。截至最近一個季度末，野村資產管理有限公司持有 Astera Labs 0.36% 的股份，價值 53,902,000 美元。</p>
<ul>
<li>跟隨資金：3 只機構持股比例高的股票</li>
</ul>
<p>其他幾家大型投資者最近也買賣了該股票的股份。Oliver Lagore Vanvalin 投資集團在第二季度新購入了 Astera Labs 的股份，價值約 29,000 美元。Bernard Wealth Management Corp.在第二季度購買了 Astera Labs 的新股份，價值約 36,000 美元。Clearstead Trust LLC 在第二季度將其在 Astera Labs 的持倉提高了 46,100.0%。Clearstead Trust LLC 現在持有 462 股該公司股票，價值 42,000 美元，此前在此期間又購買了 461 股。Harbour Investments Inc.在第一季度增持了 351.7% 的 Astera Labs 股份。Harbour Investments Inc.現在持有 795 股該公司股票，價值 47,000 美元，此前在上個季度又購買了 619 股。最後，Hazlett Burt &amp; Watson Inc.在第一季度增持了 1,670.0% 的 Astera Labs 股份。Hazlett Burt &amp; Watson Inc.現在持有 885 股該公司股票，價值 53,000 美元，此前在上個季度又購買了 835 股。機構投資者和對沖基金持有該公司 60.47% 的股份。</p>
<h2>分析師評級變動</h2>
<p>多位分析師最近對 ALAB 股票發表了評論。TD Cowen 將 Astera Labs 的目標價從 225.00 美元下調至 170.00 美元，並在 11 月 5 日的研究報告中對該股票給予了 “持有” 評級。德意志銀行將 Astera Labs 的目標價從 160.00 美元上調至 200.00 美元，並在 9 月 2 日的報告中給予該股票 “買入” 評級。Evercore ISI 將 Astera Labs 的目標價從 104.00 美元上調至 215.00 美元，並在 8 月 6 日的報告中給予該公司 “跑贏大盤” 評級。Needham &amp; Company LLC 將 Astera Labs 的目標價從 205.00 美元上調至 220.00 美元，並在 11 月 5 日的研究報告中給予該公司 “買入” 評級。最後，Northland Securities 在週一為 Astera Labs 設定了 175.00 美元的目標價。十四位投資分析師對該股票給予了 “買入” 評級，八位分析師給予了 “持有” 評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，平均目標價為 184.82 美元。</p>
<ul>
<li>這 3 只被打壓的股票準備反彈嗎？</li>
</ul>
<p><strong>查看我們最新的 ALAB 股票分析</strong></p>
<h2>Astera Labs 的內部交易</h2>
<p>在相關消息中，董事 Jack R. Lazar 在 8 月 27 日的交易中出售了 22,500 股公司的股票。股票以平均價格 178.42 美元出售，總價值為 4,014,450.00 美元。交易完成後，該董事持有 97,351 股公司的股票，價值約為 17,369,365.42 美元。這筆交易代表其持倉減少了 18.77%。該交易在向 SEC 提交的文件中披露，相關文件可通過此鏈接訪問。此外，首席法律顧問 Philip Mazzara 在 10 月 1 日的交易中出售了 10,000 股 Astera Labs 的股票。該股票以平均價格 192.16 美元出售，總交易額為 1,921,600.00 美元。交易完成後，首席法律顧問持有 151,573 股該公司的股票，價值約為 29,126,267.68 美元。這筆交易使其持股減少了 6.19%。該銷售的披露信息可在 SEC 的文件中找到。在過去的九十天裏，內部人士共出售了 225,500 股公司股票，價值 39,531,460 美元。公司內部人士持有該公司 12.50% 的股份。</p>
<h2>Astera Labs 股票下跌 2.0%</h2>
<ul>
<li>每個 AI ETF 都在購買的 4 只股票——而且它們並不是你想的那樣</li>
</ul>
<p>NASDAQ ALAB 的股票在週二開盤價為 141.39 美元。Astera Labs, Inc.的 12 個月低點為 47.13 美元，12 個月高點為 262.90 美元。該公司的市值為 238.8 億美元，市盈率為 127.38，市盈率/增長比率為 2.69，貝塔值為 1.38。該公司的 50 日簡單移動平均線為 192.00 美元，200 日簡單移動平均線為 144.85 美元。</p>
<p>Astera Labs（NASDAQ:ALAB - 獲取免費報告）最近在 11 月 4 日發佈了季度財報。該公司報告每股收益為 0.49 美元，超出分析師共識預期的 0.39 美元，超出幅度為 0.10 美元。該公司季度收入為 2.3058 億美元，而分析師預期為 2.0642 億美元。Astera Labs 的股本回報率為 13.48%，淨利潤率為 27.50%。Astera Labs 的收入同比增長了 103.9%。去年同期，該公司每股收益為 0.23 美元。Astera Labs 已將其 2025 年第四季度的指導目標設定為 0.50-0.510 每股收益。作為一個整體，賣方分析師預計 Astera Labs, Inc.在當前財年將發佈 0.34 每股收益。</p>
<h2>關於 Astera Labs</h2>
<p>（免費報告）</p>
<p>Astera Labs, Inc.設計、製造和銷售基於半導體的雲和人工智能基礎設施連接解決方案。其智能連接平台由一系列數據、網絡和內存連接產品組成，這些產品建立在統一的軟件定義架構上，使客户能夠大規模部署和運營高性能的雲和人工智能基礎設施。</p>
<h2>另請參閲</h2>
<ul>
<li>我們更看好的五隻股票超過 Astera Labs</li>
<li>三隻能夠幫助抵禦通貨膨脹的超市股票</li>
<li>惠而浦的最壞時刻可能已經過去——未來有上漲機會</li>
<li>在 52 周高點上盈利交易股票</li>
<li>這三隻被打壓的股票可能是你本季度最佳的購買機會</li>
<li>股票市場行業：它們是什麼，數量有多少？</li>
<li>D-Wave 在財報季後與量子競爭對手相比如何？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Astera Labs 嗎？</h2>
<p>在考慮 Astera Labs 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Astera Labs 並不在名單上。</p>
<p>雖然 Astera Labs 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ALAB

野村控股

<p>野村資產管理有限公司在第二季度將其在 Astera Labs, Inc.的股份增加了 50.2%，目前持有 596,130 股，價值 5390 萬美元。機構投資者持有 Astera Labs 股票的 60.47%。分析師的評級意見不一，普遍共識為 “適度買入”，平均目標價為 184.82 美元。最近的內部交易包括董事 Jack R. Lazar 和總法律顧問 Philip Mazzara 的大量股票出售。Astera Labs 的股票開盤價為 141.39 美元，市值為 238.8 億美元</p>

<p>Nomura Asset Management Co. Ltd. boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 50.2% in the second quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The institutional investor owned 596,130 shares of the company's stock after buying an additional 199,330 shares during the period. Nomura Asset Management Co. Ltd. owned 0.36% of Astera Labs worth $53,902,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>野村資產管理有限公司在第二季度增持了 Astera Labs, Inc.（NASDAQ:ALAB - 免費報告）50.2% 的股份，根據其最近向證券交易委員會提交的文件顯示。這家機構投資者在此期間購買了額外的 199,330 股後，持有該公司 596,130 股股票。截至最近一個季度末，野村資產管理有限公司持有 Astera Labs 0.36% 的股份，價值 53,902,000 美元。</p>
</div><ul>
<li>Follow the Money: 3 Stocks With High Institutional Ownership</li>
</ul>
<div class="lb-trans"><ul>
<li>跟隨資金：3 只機構持股比例高的股票</li>
</ul>
</div><p>Several other large investors have also recently bought and sold shares of the stock. Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs in the 2nd quarter worth approximately $29,000. Bernard Wealth Management Corp. bought a new stake in Astera Labs during the second quarter worth approximately $36,000. Clearstead Trust LLC lifted its position in Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company's stock worth $42,000 after purchasing an additional 461 shares during the period. Harbour Investments Inc. boosted its stake in Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after purchasing an additional 619 shares in the last quarter. Finally, Hazlett Burt &amp; Watson Inc. boosted its stake in Astera Labs by 1,670.0% during the 1st quarter. Hazlett Burt &amp; Watson Inc. now owns 885 shares of the company's stock valued at $53,000 after purchasing an additional 835 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家大型投資者最近也買賣了該股票的股份。Oliver Lagore Vanvalin 投資集團在第二季度新購入了 Astera Labs 的股份，價值約 29,000 美元。Bernard Wealth Management Corp.在第二季度購買了 Astera Labs 的新股份，價值約 36,000 美元。Clearstead Trust LLC 在第二季度將其在 Astera Labs 的持倉提高了 46,100.0%。Clearstead Trust LLC 現在持有 462 股該公司股票，價值 42,000 美元，此前在此期間又購買了 461 股。Harbour Investments Inc.在第一季度增持了 351.7% 的 Astera Labs 股份。Harbour Investments Inc.現在持有 795 股該公司股票，價值 47,000 美元，此前在上個季度又購買了 619 股。最後，Hazlett Burt &amp; Watson Inc.在第一季度增持了 1,670.0% 的 Astera Labs 股份。Hazlett Burt &amp; Watson Inc.現在持有 885 股該公司股票，價值 53,000 美元，此前在上個季度又購買了 835 股。機構投資者和對沖基金持有該公司 60.47% 的股份。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>A number of analysts have recently commented on ALAB shares. TD Cowen dropped their price objective on Astera Labs from $225.00 to $170.00 and set a &#34;hold&#34; rating on the stock in a research note on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on Astera Labs from $160.00 to $200.00 and gave the stock a &#34;buy&#34; rating in a report on Tuesday, September 2nd. Evercore ISI upped their price target on shares of Astera Labs from $104.00 to $215.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday, August 6th. Needham &amp; Company LLC raised their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, November 5th. Finally, Northland Securities set a $175.00 price objective on shares of Astera Labs in a research note on Monday. Fourteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $184.82.</p>
<div class="lb-trans"><p>多位分析師最近對 ALAB 股票發表了評論。TD Cowen 將 Astera Labs 的目標價從 225.00 美元下調至 170.00 美元，並在 11 月 5 日的研究報告中對該股票給予了 “持有” 評級。德意志銀行將 Astera Labs 的目標價從 160.00 美元上調至 200.00 美元，並在 9 月 2 日的報告中給予該股票 “買入” 評級。Evercore ISI 將 Astera Labs 的目標價從 104.00 美元上調至 215.00 美元，並在 8 月 6 日的報告中給予該公司 “跑贏大盤” 評級。Needham &amp; Company LLC 將 Astera Labs 的目標價從 205.00 美元上調至 220.00 美元，並在 11 月 5 日的研究報告中給予該公司 “買入” 評級。最後，Northland Securities 在週一為 Astera Labs 設定了 175.00 美元的目標價。十四位投資分析師對該股票給予了 “買入” 評級，八位分析師給予了 “持有” 評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，平均目標價為 184.82 美元。</p>
</div><ul>
<li>Are These 3 Beaten-Down Stocks Ready to Rebound?</li>
</ul>
<div class="lb-trans"><ul>
<li>這 3 只被打壓的股票準備反彈嗎？</li>
</ul>
</div><p><strong>View Our Latest Stock Analysis on ALAB</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 ALAB 股票分析</strong></p>
</div><h2>Insider Transactions at Astera Labs</h2>
<div class="lb-trans"><h2>Astera Labs 的內部交易</h2>
</div><p>In related news, Director Jack R. Lazar sold 22,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the transaction, the director owned 97,351 shares of the company's stock, valued at approximately $17,369,365.42. This trade represents a 18.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the transaction, the general counsel owned 151,573 shares in the company, valued at approximately $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 225,500 shares of company stock valued at $39,531,460 over the last ninety days. Corporate insiders own 12.50% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，董事 Jack R. Lazar 在 8 月 27 日的交易中出售了 22,500 股公司的股票。股票以平均價格 178.42 美元出售，總價值為 4,014,450.00 美元。交易完成後，該董事持有 97,351 股公司的股票，價值約為 17,369,365.42 美元。這筆交易代表其持倉減少了 18.77%。該交易在向 SEC 提交的文件中披露，相關文件可通過此鏈接訪問。此外，首席法律顧問 Philip Mazzara 在 10 月 1 日的交易中出售了 10,000 股 Astera Labs 的股票。該股票以平均價格 192.16 美元出售，總交易額為 1,921,600.00 美元。交易完成後，首席法律顧問持有 151,573 股該公司的股票，價值約為 29,126,267.68 美元。這筆交易使其持股減少了 6.19%。該銷售的披露信息可在 SEC 的文件中找到。在過去的九十天裏，內部人士共出售了 225,500 股公司股票，價值 39,531,460 美元。公司內部人士持有該公司 12.50% 的股份。</p>
</div><h2>Astera Labs Stock Down 2.0%</h2>
<div class="lb-trans"><h2>Astera Labs 股票下跌 2.0%</h2>
</div><ul>
<li>4 Stocks Every AI ETF Is Buying—And They’re Not What You Think</li>
</ul>
<div class="lb-trans"><ul>
<li>每個 AI ETF 都在購買的 4 只股票——而且它們並不是你想的那樣</li>
</ul>
</div><p>Shares of NASDAQ ALAB opened at $141.39 on Tuesday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The company has a market cap of $23.88 billion, a price-to-earnings ratio of 127.38, a P/E/G ratio of 2.69 and a beta of 1.38. The business has a fifty day simple moving average of $192.00 and a 200-day simple moving average of $144.85.</p>
<div class="lb-trans"><p>NASDAQ ALAB 的股票在週二開盤價為 141.39 美元。Astera Labs, Inc.的 12 個月低點為 47.13 美元，12 個月高點為 262.90 美元。該公司的市值為 238.8 億美元，市盈率為 127.38，市盈率/增長比率為 2.69，貝塔值為 1.38。該公司的 50 日簡單移動平均線為 192.00 美元，200 日簡單移動平均線為 144.85 美元。</p>
</div><p>Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.10. The firm had revenue of $230.58 million for the quarter, compared to analysts' expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs's revenue was up 103.9% on a year-over-year basis. During the same quarter last year, the business posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Astera Labs（NASDAQ:ALAB - 獲取免費報告）最近在 11 月 4 日發佈了季度財報。該公司報告每股收益為 0.49 美元，超出分析師共識預期的 0.39 美元，超出幅度為 0.10 美元。該公司季度收入為 2.3058 億美元，而分析師預期為 2.0642 億美元。Astera Labs 的股本回報率為 13.48%，淨利潤率為 27.50%。Astera Labs 的收入同比增長了 103.9%。去年同期，該公司每股收益為 0.23 美元。Astera Labs 已將其 2025 年第四季度的指導目標設定為 0.50-0.510 每股收益。作為一個整體，賣方分析師預計 Astera Labs, Inc.在當前財年將發佈 0.34 每股收益。</p>
</div><h2>About Astera Labs</h2>
<div class="lb-trans"><h2>關於 Astera Labs</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.</p>
<div class="lb-trans"><p>Astera Labs, Inc.設計、製造和銷售基於半導體的雲和人工智能基礎設施連接解決方案。其智能連接平台由一系列數據、網絡和內存連接產品組成，這些產品建立在統一的軟件定義架構上，使客户能夠大規模部署和運營高性能的雲和人工智能基礎設施。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參閲</h2>
</div><ul>
<li>Five stocks we like better than Astera Labs</li>
<li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation</li>
<li>Whirlpool’s Worst May Be Over—Upside Opportunity Ahead</li>
<li>Profitably Trade Stocks at 52-Week Highs</li>
<li>These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter</li>
<li>Stock Market Sectors: What Are They and How Many Are There?</li>
<li>How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Astera Labs</li>
<li>三隻能夠幫助抵禦通貨膨脹的超市股票</li>
<li>惠而浦的最壞時刻可能已經過去——未來有上漲機會</li>
<li>在 52 周高點上盈利交易股票</li>
<li>這三隻被打壓的股票可能是你本季度最佳的購買機會</li>
<li>股票市場行業：它們是什麼，數量有多少？</li>
<li>D-Wave 在財報季後與量子競爭對手相比如何？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALAB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Astera Labs Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Astera Labs 嗎？</h2>
</div><p>Before you consider Astera Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Astera Labs 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Astera Labs 並不在名單上。</p>
</div><p>While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Astera Labs 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Astera Labs, Inc. $ALAB 的持股量被野村資產管理有限公司提升